RenovoRx, Inc.
Nasdaq · Healthcare · Surgical & Medical Instruments & Apparatus · Mountain View, CA
RNXT chart
What traders are saying about $RNXT
Latest postsRenovoRx, Inc. news
- RenovoRx, Inc. Estimates – NASDAQ:RNXT
TradingView ·
- RenovoRx, Inc. (RNXT) stock price, news, quote and history
Yahoo Finance UK ·
- RenovoRx to Report Third Quarter 2026 Financial Results and Business Highlights on November 5, 2026
Yahoo Finance ·
- RenovoRx to report Q3 2026 results and host con...
Pluang ·
- RenovoRx Advances TAMP™ into Borderline Resectable Pancreatic Cancer with First Patient Enrolled in Investigator-Initiated PRISM-TAMP Trial
Yahoo Finance ·
- RenovoRx Announces Peer-Reviewed Publication Highlighting the TAMP™ Platform's Potential to Improve Chemotherapeutic Delivery for Locally Advanced Pancreatic Cancer
Yahoo Finance ·
- RenovoRx H.C. Wainwright Presentation to Highlight RenovoCath Growth and Phase III TIGeR-PaC Timeline
investorshub.advfn.com ·
- RenovoRx to Present at H.C. Wainwright 28th Annual Global Investment Conference, September 14th-16th
Yahoo Finance ·
- RenovoRx Highlights Peer-Reviewed Publication of Pharmacokinetic and Pharmacodynamic (PK/PD) Data Supporting TAMP™ Platform’s Targeted Drug-Delivery in Locally Advanced Pancreatic Cancer
Yahoo Finance ·
- RenovoRx Regains Compliance with Nasdaq Minimum Bid Price Requirement
Yahoo Finance ·
- RenovoRx Receives Notice of Allowance for New U.S. Patent Covering RenovoCath®, an Advanced Dual-Occlusion Catheter, for Targeted Therapeutic Drug-Delivery for Cancer Treatment
Yahoo Finance ·
- RenovoRx Eyes 2027 TIGeR-PaC Readout as RenovoCath Expands to 21 Centers
marketbeat.com ·
RenovoRx, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $1.1M | $43,000 | – | – |
| Net income | -$11.2M | -$8.8M | -$10.2M | -$9.9M |
| Diluted EPS | $-0.32 | $-0.40 | $-0.99 | $-1.09 |
| Total assets (year end) | $8.1M | $8.1M | $1.5M | $7.3M |
| Cash and equivalents (year end) | $7.0M | $7.2M | $1.2M | $4.4M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About RenovoRx, Inc.
- Ticker
- RNXT (Nasdaq)
- Industry
- Surgical & Medical Instruments & Apparatus
- Headquarters
- Mountain View, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1574094
Frequently asked questions
What exchange is RenovoRx, Inc. listed on?
RenovoRx, Inc. trades on the Nasdaq under the ticker symbol RNXT.
What industry is RenovoRx, Inc. in?
RenovoRx, Inc. is classified by the SEC under "Surgical & Medical Instruments & Apparatus", part of the Healthcare sector on StockTweeting.
Where is RenovoRx, Inc. headquartered?
RenovoRx, Inc.'s business address on file with the SEC is in Mountain View, CA.
When does RenovoRx, Inc.'s fiscal year end?
RenovoRx, Inc.'s fiscal year ends on December 31.
How much revenue did RenovoRx, Inc. report?
RenovoRx, Inc. reported $1.1M in revenue for calendar year 2025, according to its SEC filings.